Logotype for Planet 13 Holdings Inc

Planet 13 (PLTH) Q2 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Planet 13 Holdings Inc

Q2 2025 earnings summary

22 May, 2026

Executive summary

  • Q2 2025 revenue was $26.9 million, down from $28 million in Q1 and 13.6% year-over-year, reflecting disciplined execution amid challenging market conditions and increased competition in Nevada and Florida.

  • Net loss widened to $13.3 million from $8.1 million year-over-year, driven by lower gross profit and severance/cost reduction expenses.

  • Las Vegas SuperStore revenue rose 7% sequentially to $12 million, despite an 11% drop in visitor traffic and a 14% decline in statewide cannabis flower sales year-over-year.

  • Neighborhood store network revenue was $12.2 million, down 9% from Q1, with ongoing efforts to rebuild customer trust and expand product offerings in Florida.

  • Wholesale revenue declined to $2.7 million from $3.4 million in Q1, as the company prioritized margin by channeling more products through its own dispensaries.

Financial highlights

  • Gross profit was $11.7 million (43.4% margin), down from $15.8 million (50.9% margin) year-over-year, but up from 42.8% in Q1.

  • Adjusted EBITDA loss was $2.4 million, swinging from positive $3.2 million in Q2 2024 and improving slightly from $2.5 million in Q1.

  • Operating cash used was $1.2 million, a significant improvement over Q1.

  • Sales and marketing expense increased to $1.6 million, while G&A declined to $13.6 million, reflecting early benefits from cost reduction initiatives.

  • Total expenses decreased 4.6% to $18.5 million, reflecting early savings from cost reduction measures.

Outlook and guidance

  • Focus remains on offsetting price compression with higher volumes, especially in Florida and Las Vegas, while maintaining operational discipline.

  • Cost reduction programs are expected to yield over $1 million in G&A savings in both Q3 and Q4, with further marketing expense reductions anticipated.

  • The BHO extraction lab in Florida is on track for completion in Q4, enabling a full suite of products and supporting future growth.

  • Management expects recent cost reduction actions to improve financial performance over time while maintaining quality and service.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more